跳至主要内容
临床试验/NCT03910309
NCT03910309终止不适用

A Prospective Investigation Comparing Bone Graft Extenders in Transforaminal Interbody Fusions (TLIF) With an Acid Etched Titanium Implant: A Clinical Outcomes and Cost Analysis

Titan Spine8 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
75
试验地点
8
主要终点
Function measured by oswestry disability index

研究概览

简要总结

This is a prospective, multi-center controlled observational clinical study. All subjects will receive Titan Endoskeleton TT/TO acid etched titanium implant for the planned procedure. Each site will have a predetermined bonegraft extender to be used in all enrolled subjects at that site.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be 18-75 years of age, and skeletally mature
  • Have clinical and radiological evidence of degenerative disc disease at one or two levels of the lumbar spine between L2-S
  • May also have spondylosis, spinal stenosis, or spondylolisthesis at these levels.
  • In the opinion of the treating surgeon, must already be a qualified candidate for lumbar fusion surgery including 6 months of conservative care prior to surgical intervention.
  • Psychosocially, mentally and physically able to comply with protocol, post-operative management and follow-up schedule.
  • Subject must understand and sign the written Informed Consent.

排除标准

  • Previous history of fusion surgery at the index level(s).
  • Clinical, laboratory and/or radiological evidence of back pain secondary to acute or chronic infection, malignancy, other space occupying lesions and metabolic bone demineralization diseases (e.g. osteomalacia, gout, Paget's disease etc.)
  • Osteoporosis defined as a DEXA bone density measurement T score ≤ 2.5 (Necessity for DEXA scan will be determined by investigator's standard of care)
  • Any terminal or autoimmune disease including but not limited to HIV infection, rheumatoid arthritis or lupus.
  • Any other concurrent medical disease that might impair normal healing process.
  • Morbid obesity (BMI ≥ 40 kg/m2).
  • Investigational drug or device use within 30 days.
  • Currently a prisoner.
  • Currently experiencing a major mental illness (psychosis, schizophrenia, major affective disorder) which may indicate that the symptoms are psychological rather than of physical origin.

结局指标

主要结局

Function measured by oswestry disability index

时间窗: 2 years

10 question score

Pain measured by VAS

时间窗: 2 years

1 to 10

次要结局

  • Success of fusion(3 months, 6 months, 12 months, 24 months)

研究者

发起方
Titan Spine
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验